Retatrutide peptidescompoundsmolecules, a dual agonistactivatorstimulant of glucagon-likeGLP-1peptide-1 receptor and glucose-dependentglucose-regulatedglucose-insulinotropic polypeptide receptor, represents a novelnewinnovative approach to managingtreatingaddressing type 2 diabetesconditiondisease.